BioTech startup Visibuilt is developing biobased alternatives to conventional carbon-intensive construction binders. It has now announced it has secured €3.34 million in funding to move from lab pilots towards market validation and industry tests.
The round was co-led by EIFO and Unconventional Ventures followed by Proptechfonden and backed again by earlier investor EMDFonden.
“Closing this Seed round is an important milestone for Visibuilt. It enables us to mature our technical platform, validate our solution at a larger scale, and take the next steps towards the market,”
says Line Kloster Pedersen, CEO and founder of Visibuilt.
Founded in 2022, Visibuilt develops a mycelium-based binder solution for the construction and infrastructure industries. Founded by Line Kloster Pedersen and Oleksii Rebrov, the startup combines biotechnology and materialscience to create lower-carbon alternatives to conventional construction materials. Last year it created the worlds first mycelium cultivated outdoor paver – a natural alternative to cement.
“Concrete and asphalt production are among the largest sources of carbondioxid emissions globally. If we are to truly reduce emissions, it requires new solutions in heavy industries. Visibuilt has an approach that could become an important piece of that transition,”
says Sara Sande, Managing Director, Partner and Head of Direct Thematic Venture at EIFO.
The binder technology, visiBINDER, is a mycelium-based binder designed for paving and infrastructure applications. The technology is designed to offer a less energy intensive solution for paving materials while meeting the durability and performance requirements of outdoor applications. These cultivated pavers where pioneered last year at the Fælledby construction site in Copenhagen, following extensive testing.
“At Unconventional Ventures, we look for companies where the impact case and the commercial case are structurally identical. Visibuilt is that company. Every tonne of visiBINDER placed in a paving application displaces a tonne of fossil binder, generates royalty revenue, and reduces the embedded carbon of the infrastructure it goes into,”
says Thea Messel, General Partner, Unconventional Ventures
The new funding will allow Visibuilt to expand testing and validation activities, establish the production setup required for larger-scale trials, and strengthen the team with additional technical and commercial expertise.
“Line has built active industrial testing relationships with Denmark’s leading concrete paver manufacturer and Copenhagen Municipality within two years of founding – without a finished production setup and without a fully derisked product. That is an unusual execution signal for a HardTech founder at this stage, and it is why we co-led,”
says Thea Messel
